FDA Investigator CDR Kimberly Y Martin
CDR Kimberly Y Martin has inspections in 3 countries as of 07 Sep 2023. CDR Kimberly Y Martin has collaborated with a combined 1464 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
133
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Brazil,
Mexico
Co-Investigator(s):
A Williams,
Adam J Taylor,
Alanna Lmussawwir Bias,
Amanda L Baskin,
Amina Bashir,
Andrace Lde Yampert,
Andrea D Swingle,
Ava M Bowman,
Barbara A Rusin,
Benjamin J Smith,
Bernard P Heidt,
Brandi N Mcgrady,
Brian J Davis,
Brian P Hendrickson,
Brittany M Lowe,
Bruce,
Calvin K Cook,
Catherine V Quinlan,
Charles E Frelix,
Charles M Spyr,
Corrine M Carter,
Crystal M Young Lewis,
Daniel J Gorski,
David A Paterson,
David L Duncan,
Dawn C Olenjack,
Debara R Reese,
Downer,
Erma Zaimova,
Hans T Meyers,
Helen B Ricalde,
Ifueko Osemwota,
James A Lane,
James N Rench,
Jeffrey A Sommers,
Jennifer L Sheehan,
John D Jaworski,
Joseph R Strelnik,
Kelley L Clark,
Kimberly A Dux,
Kristina Nastovski,
L'oreal F Walker,
Larry K Austin,
Laureen F Kononen,
Leigh Anne Myers,
Lesley Maep Lutao,
Lewis K Antwi,
Lisa P Oakes,
Maira P Brading,
Martin K Yau, PhD,
Matthew J Gretkierewicz,
Megan C Amye,
Megan C Spencer,
Meisha R Sampson,
Meisha Waters,
Michael F Skelly, PhD,
Misty D Harvey,
Myra K Casey,
Nancy A Bellamy,
Nancy L Neiger,
Natalie A Mickelsen, DVM,
Neal D Singletary, PhD,
Neali H Lucas,
Nerizza B Guerin,
Patricia H Dlugosz,
Patrick B Cummings,
Rasha Bamieh,
Robert M Barbosa,
Seongeun Cho (Julia), PhD,
Sherri J Jackson,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Susan M North,
Theodore N Sietsema,
Thursaml,
Travis S Bradley,
Uttaniti Limchumroon (Tom),
Vera M Anderson,
William R Brubaker,
Xikui Chen (nmi), PhD
CDR Kimberly Y Martin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more